Latest stock market news, company updates, and price movements. Stay updated with market trends, earnings insights, and investment analysis.
Adani Enterprises expanded its QIP to ₹15,000 crore after bids near ₹38,000 crore, drawing large domestic mutual funds and global institutions at an indicative ₹2,883 issue price.
ideaForge Technology’s stock snapshot shows ₹854 price (6 Jul 2026), ₹3,565.44 crore market cap and mixed profitability signals, alongside sharp swings over recent quarters.
NFRA has begun its process into audit issues flagged in SEBI’s interim order on Rajesh Exports, as ED searches allege FEMA violations linked to overseas transactions.
India is scaling its National Green Hydrogen Mission through SIGHT allocations, fresh R&D funding, and new production awards, as it works toward a 5 MMT annual target by 2030.
GIFT Nifty fell 130 points as US-Iran tensions lifted crude prices, pointing to a weaker start for Sensex and Nifty amid soft global cues and foreign selling.
Goa Carbon’s Q3 FY26 unaudited results showed higher income but a wider loss, while subsequent quarterly data points to a swing back to profit in March 2026.
Indian Overseas Bank’s July 7, 2026 AGM will seek shareholder approval for a ₹5,000 crore equity raise, loss write-off from share premium, and an MD and CEO tenure extension.
Ceigall India reported new appointed dates, milestone progress and fresh L1 status across multiple HAM road projects, including Indore-Ujjain, Punjab connectivity, Ayodhya and Ludhiana.
Chambal Breweries & Distilleries disclosed valuation-only audited results for Apr-May 2026, reporting total income of ₹0.01 crore, expenses of ₹0.07 crore and a net loss of ₹0.06 crore.
Chambal Breweries has approved an amalgamation with Invade Agro with a 5:2 share swap, subject to shareholder, creditor and NCLT approvals after filings under SEBI rules.
Kkalpana Plastick’s latest available metrics show a ₹27-range share price, ~₹15 crore market cap, high P/E, and a ₹17.77 to ₹35.78 52-week band.
Restaurant Brands Asia saw promoter holding drop to 9.22% in the Jun 2026 quarter, as a ₹1,500 crore change-of-control transaction and open offer drew focus.
Orchid Pharma and Pharmasyntez signed a Russia licensing and supply pact for Exblifep, as Orchid targets FY27 out-licensing milestones across the US and other regions.
Cipla shares came under pressure after the USFDA marked its Greece-linked manufacturing facility as OAI and Lanreotide Injection supply was flagged as disrupted until FY27.
Glenmark Pharmaceuticals is reshaping its portfolio around innovation, licensing and branded growth, using partnerships and its AbbVie ISB-2001 deal to move beyond generics.
Brokerage reports say AMFI’s July 2026 market-cap review may upgrade BSE and other midcaps to large-cap, lifting the cut-off and triggering mutual fund rebalancing.